{"success":true,"data":{"pressRelease":{"id":"172672","rtpr_id":"nGNE2FbZSd-20261019","ticker":"DSFIR","exchange":"Euronext Amsterdam","all_tickers":["DSFIR"],"title":"REG-dsm-firmenich shareholders elect Richard Ridinger as Chairman of the Board of Directors","author":"Globe Newswire","published_at":"2026-10-19T12:49:46.049Z","article_body":"Press Release\n\nAd hoc announcement pursuant to article 53 LR\n\ndsm-firmenich shareholders elect Richard Ridinger as Chairman of the Board of\nDirectors\n\nKaiseraugst (Switzerland), Maastricht (Netherlands), October 19, 2026\n\ndsm-firmenich, innovators in nutrition, health, and beauty, today confirms\nthat shareholders at the Extraordinary General Meeting (EGM) held on October\n19, 2026, elected Richard Ridinger as Chairman of the Board of Directors, as\npreviously announced on August 18\n(https://www.globenewswire.com/Tracker?data=AasY4nFmgwo2NJXrIAcjMezgd-3Iyko9eRvXsZs-z6Ajh7Xzg1a51fpMYHr1zYnCBS1XpA0hLq6O7PmLeMFCIOPivRrB1g9Dyyh31ksJbsAA-ktk9wkYkhfOxJCVueBwKUVJfm2vDQb5qfMVmwtBBkuHh-nIDBrVb2jk7L9nIISvsR-c69CEZjtW3hDfEfavWaXR4TIGXOqqtjuBdFkDuoPDfZ_i7xPWnRS9dLypKvWk1uMNN2vdIlXpn9lyViY1of2wQ3aXi2aqP-W2L-0yc0jHFdB1hAxW_ptE0gH8vztJaxI9PzJfVGDYo6OSivownLNlujZAs7htLewHGHjgog==).\n\nRichard Ridinger succeeds Thomas Leysen, who has retired from the Board.\nThomas played a pivotal role in shaping the company’s strategic direction\nand establishing a strong foundation for its next phase of growth and value\ncreation.\n\nRichard Ridinger has served as an independent member of the Board of Directors\nof dsm-firmenich since 2023 and, in addition to his role as Chairman, has also\nbeen elected as a member of the Compensation Committee. He brings extensive\nexecutive and board-level experience across Pharma, Home & Personal Care, and\nNutrition & Health, as well as a deep understanding of the company, its\nstrategy and stakeholders.\n\nThe Board looks forward to working with Richard Ridinger as dsm-firmenich\ncontinues to execute its strategy, and create sustainable long-term value for\nshareholders and other stakeholders. The Board also expresses its sincere\ngratitude to Thomas for his outstanding leadership and dedication during his\ntenure.\n\nThe detailed voting results of the Extraordinary General Meeting are available\non the company’s website\n(https://www.globenewswire.com/Tracker?data=R-EYqzODzZbKGgdaU7gpKDjqmahuCV-kEmOzDzJkzIwSe0IkLioRIJb5Y3CRKretMpqpeYc7TwtyvN7jd0_Mn5ypPJGOVd2Ciig_HAk5grUhpeWo3VnUYuE9qJgLSh3VL2T4nkHvMNgwAJZAAyA3-5K28jCMIk9-SYNXBo2U3pSl1vZ3vVWL8JGULOtRn7Y6).\n\nBiography Richard Ridinger\nA full biography of Richard Ridinger is available here\n(https://www.globenewswire.com/Tracker?data=eAzuRKwbGu8g6rjkyx1BZtl_4Pu6Xizd5cS-JBrRa5rkWOFlz58Wa3CyVwPa-O0ewHWGxqhL6IHTbKDfc-iwJeIV_Pj6qOhStx3V41QAhogTO8ZYyBid1Ft2Jrrwzb4d3-KNAVhzd62NAzl9Ghe8htO-mtLdMRSPJfyiywxAdf5hIGr4RI88ddZZZ7Gk7JqGq9B0t7DIeD6QYj5tsbqGhVRjygcEoCs43HksAnZDBw8tgfVT1PJiHx15qw45q-PsWenHKO5unes3VeM4HfZ_k7ml37xbmQ19fg3LKsMYAnajfknsFo5UKg1JImXtTqma)\nand a portrait picture can be downloaded here\n(https://www.globenewswire.com/Tracker?data=eAzuRKwbGu8g6rjkyx1BZnwPTRQ8enB1rKOO2t4--jc9pbjWTaTNsIglx3PaEUS61xlHFy2D3IpQF5soEig0iIsR5jiZ4jXdF20D7dj6fZgXP5Fk4gwybP6nmztAzzblYA7X05g1aWaNJIvpwh_Vrn2yLNS7ZbOBQKXSR0lVWPKB1FGJwQJJyNP1Vjs4-dAt72lxHGQ9aEoIvC8e1yh6ntm6EPFwn8Jj2qofy2I1jX_nwUYcVJ0NbQBMST5Uza4L).\n\nFor more information\n\nMedia relations \nRobin Roothans\ntel. +41 (0)79 280 03 96\ne-mail media@dsm-firmenich.com\n\nInvestor relations\nDave Huizing\ntel. +31 (0)88 425 7306\ne-mail investors@dsm-firmenich.com\n\nAbout dsm-firmenich\nAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents,\nmanufactures, and combines vital nutrients, flavors, and fragrances for the\nworld’s growing population to thrive. With our comprehensive range of\nsolutions, with natural and renewable ingredients and renowned science and\ntechnology capabilities, we work to create what is essential for life,\ndesirable for consumers, and more sustainable for people and the planet.\ndsm-firmenich is a Swiss company, listed on Euronext Amsterdam and SIX Swiss\nExchange, with operations in almost 60 countries and revenues of more than\n€9 billion for its Continuing Operations following the divestment of Animal\nNutrition & Health. With a diverse, worldwide team of nearly 21,000 employees,\nwe bring progress to life every day, everywhere, for billions of people.\nwww.dsm-firmenich.com\n\nForward-looking statements\nThis press release may contain forward-looking statements with respect to\ndsm-firmenich’s future performance and position. Such statements are based\non current expectations, estimates and projections of dsm-firmenich and\ninformation currently available to the company. dsm-firmenich cautions readers\nthat such statements involve certain risks and uncertainties that are\ndifficult to predict and therefore it should be understood that many factors\ncan cause actual performance, transaction progress and positions to differ\nmaterially from these statements. dsm-firmenich has no obligation to update\nthe statements contained in this press release, unless required by law. This\ncommunication contains information that qualifies as inside information within\nthe meaning of Article 7(1) of the EU Market Abuse Regulation. The English\nlanguage version of this press release prevails over other language versions.\n\nAttachment\n*     Press release_dsm-firmenich shareholders elect new Chair of the Board of\nDirectors_20261019_FINAL\n(https://ml-eu.globenewswire.com/Resource/Download/f905419f-b124-4e37-a5ca-cb658f82ff5f)","article_body_html":"","raw_payload":{"data":{"id":"nGNE2FbZSd-20261019","title":"REG-dsm-firmenich shareholders elect Richard Ridinger as Chairman of the Board of Directors","author":"Globe Newswire","ticker":"DSFIR","created":"2026-10-19T12:49:46.049Z","tickers":["DSFIR"],"exchange":"Euronext Amsterdam","article_body":"Press Release\n\nAd hoc announcement pursuant to article 53 LR\n\ndsm-firmenich shareholders elect Richard Ridinger as Chairman of the Board of\nDirectors\n\nKaiseraugst (Switzerland), Maastricht (Netherlands), October 19, 2026\n\ndsm-firmenich, innovators in nutrition, health, and beauty, today confirms\nthat shareholders at the Extraordinary General Meeting (EGM) held on October\n19, 2026, elected Richard Ridinger as Chairman of the Board of Directors, as\npreviously announced on August 18\n(https://www.globenewswire.com/Tracker?data=AasY4nFmgwo2NJXrIAcjMezgd-3Iyko9eRvXsZs-z6Ajh7Xzg1a51fpMYHr1zYnCBS1XpA0hLq6O7PmLeMFCIOPivRrB1g9Dyyh31ksJbsAA-ktk9wkYkhfOxJCVueBwKUVJfm2vDQb5qfMVmwtBBkuHh-nIDBrVb2jk7L9nIISvsR-c69CEZjtW3hDfEfavWaXR4TIGXOqqtjuBdFkDuoPDfZ_i7xPWnRS9dLypKvWk1uMNN2vdIlXpn9lyViY1of2wQ3aXi2aqP-W2L-0yc0jHFdB1hAxW_ptE0gH8vztJaxI9PzJfVGDYo6OSivownLNlujZAs7htLewHGHjgog==).\n\nRichard Ridinger succeeds Thomas Leysen, who has retired from the Board.\nThomas played a pivotal role in shaping the company’s strategic direction\nand establishing a strong foundation for its next phase of growth and value\ncreation.\n\nRichard Ridinger has served as an independent member of the Board of Directors\nof dsm-firmenich since 2023 and, in addition to his role as Chairman, has also\nbeen elected as a member of the Compensation Committee. He brings extensive\nexecutive and board-level experience across Pharma, Home & Personal Care, and\nNutrition & Health, as well as a deep understanding of the company, its\nstrategy and stakeholders.\n\nThe Board looks forward to working with Richard Ridinger as dsm-firmenich\ncontinues to execute its strategy, and create sustainable long-term value for\nshareholders and other stakeholders. The Board also expresses its sincere\ngratitude to Thomas for his outstanding leadership and dedication during his\ntenure.\n\nThe detailed voting results of the Extraordinary General Meeting are available\non the company’s website\n(https://www.globenewswire.com/Tracker?data=R-EYqzODzZbKGgdaU7gpKDjqmahuCV-kEmOzDzJkzIwSe0IkLioRIJb5Y3CRKretMpqpeYc7TwtyvN7jd0_Mn5ypPJGOVd2Ciig_HAk5grUhpeWo3VnUYuE9qJgLSh3VL2T4nkHvMNgwAJZAAyA3-5K28jCMIk9-SYNXBo2U3pSl1vZ3vVWL8JGULOtRn7Y6).\n\nBiography Richard Ridinger\nA full biography of Richard Ridinger is available here\n(https://www.globenewswire.com/Tracker?data=eAzuRKwbGu8g6rjkyx1BZtl_4Pu6Xizd5cS-JBrRa5rkWOFlz58Wa3CyVwPa-O0ewHWGxqhL6IHTbKDfc-iwJeIV_Pj6qOhStx3V41QAhogTO8ZYyBid1Ft2Jrrwzb4d3-KNAVhzd62NAzl9Ghe8htO-mtLdMRSPJfyiywxAdf5hIGr4RI88ddZZZ7Gk7JqGq9B0t7DIeD6QYj5tsbqGhVRjygcEoCs43HksAnZDBw8tgfVT1PJiHx15qw45q-PsWenHKO5unes3VeM4HfZ_k7ml37xbmQ19fg3LKsMYAnajfknsFo5UKg1JImXtTqma)\nand a portrait picture can be downloaded here\n(https://www.globenewswire.com/Tracker?data=eAzuRKwbGu8g6rjkyx1BZnwPTRQ8enB1rKOO2t4--jc9pbjWTaTNsIglx3PaEUS61xlHFy2D3IpQF5soEig0iIsR5jiZ4jXdF20D7dj6fZgXP5Fk4gwybP6nmztAzzblYA7X05g1aWaNJIvpwh_Vrn2yLNS7ZbOBQKXSR0lVWPKB1FGJwQJJyNP1Vjs4-dAt72lxHGQ9aEoIvC8e1yh6ntm6EPFwn8Jj2qofy2I1jX_nwUYcVJ0NbQBMST5Uza4L).\n\nFor more information\n\nMedia relations \nRobin Roothans\ntel. +41 (0)79 280 03 96\ne-mail media@dsm-firmenich.com\n\nInvestor relations\nDave Huizing\ntel. +31 (0)88 425 7306\ne-mail investors@dsm-firmenich.com\n\nAbout dsm-firmenich\nAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents,\nmanufactures, and combines vital nutrients, flavors, and fragrances for the\nworld’s growing population to thrive. With our comprehensive range of\nsolutions, with natural and renewable ingredients and renowned science and\ntechnology capabilities, we work to create what is essential for life,\ndesirable for consumers, and more sustainable for people and the planet.\ndsm-firmenich is a Swiss company, listed on Euronext Amsterdam and SIX Swiss\nExchange, with operations in almost 60 countries and revenues of more than\n€9 billion for its Continuing Operations following the divestment of Animal\nNutrition & Health. With a diverse, worldwide team of nearly 21,000 employees,\nwe bring progress to life every day, everywhere, for billions of people.\nwww.dsm-firmenich.com\n\nForward-looking statements\nThis press release may contain forward-looking statements with respect to\ndsm-firmenich’s future performance and position. Such statements are based\non current expectations, estimates and projections of dsm-firmenich and\ninformation currently available to the company. dsm-firmenich cautions readers\nthat such statements involve certain risks and uncertainties that are\ndifficult to predict and therefore it should be understood that many factors\ncan cause actual performance, transaction progress and positions to differ\nmaterially from these statements. dsm-firmenich has no obligation to update\nthe statements contained in this press release, unless required by law. This\ncommunication contains information that qualifies as inside information within\nthe meaning of Article 7(1) of the EU Market Abuse Regulation. The English\nlanguage version of this press release prevails over other language versions.\n\nAttachment\n*     Press release_dsm-firmenich shareholders elect new Chair of the Board of\nDirectors_20261019_FINAL\n(https://ml-eu.globenewswire.com/Resource/Download/f905419f-b124-4e37-a5ca-cb658f82ff5f)"},"type":"article","timestamp":"2026-10-19T12:49:46.147580903Z","server_sent_at_ms":1792414186147},"received_at":"2026-10-19T12:49:46.198Z","source_url":null},"analysis":{"id":"160792","press_release_id":"172672","analysis_json":{"industry":{"label":"Chemicals","sector":"Materials"},"redFlags":[],"eventType":"board_change","narrative":"dsm-firmenich shareholders elected Richard Ridinger as Chairman of the Board at the Extraordinary General Meeting on October 19, 2026.\n\nRidinger, an independent board member since 2023, succeeds Thomas Leysen, who retired from the Board, and also joins the Compensation Committee.\n\nThe change was previously announced on August 18, so it confirms an anticipated governance transition rather than introducing new strategic information.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Confirmed chairman succession with continuity signal -- Ridinger elevated from within after prior announcement."},"keyFigures":{},"quotedText":"Richard Ridinger succeeds Thomas Leysen, who has retired from the Board.","namedEntities":{"people":[{"name":"Richard Ridinger","role":"Chairman of the Board (newly elected); board member since 2023"},{"name":"Thomas Leysen","role":"outgoing Chairman, retired from the Board"},{"name":"Robin Roothans","role":"Media relations contact"},{"name":"Dave Huizing","role":"Investor relations contact"}],"products":[],"companies":[{"name":"dsm-firmenich","ticker":"DSFIR","relationship":"filer"}],"dollarAmounts":[{"amount":"€9 billion","context":"revenues for Continuing Operations following divestment of Animal Nutrition & Health"}]},"materialImpact":{"score":2,"reasoning":"Chairman succession at an EGM, previously announced on August 18 and now confirmed by shareholder vote. Routine governance event with a named, board-experienced successor; no strategic or financial surprise."},"tickerRelevance":{"others":[],"primary":"DSFIR"},"globalImportance":25,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap foreign issuer","eventGravity":"routine governance confirmation","preAnnounced":true,"householdBrandBoost":"moderate European household name but limited US retail audience"}},"event_type":"board_change","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"dsm-firmenich shareholders elected Richard Ridinger as Chairman of the Board at the Extraordinary General Meeting on October 19, 2026.\n\nRidinger, an independent board member since 2023, succeeds Thomas Leysen, who retired from the Board, and also joins the Compensation Committee.\n\nThe change was previously announced on August 18, so it confirms an anticipated governance transition rather than introducing new strategic information.","key_figures":{},"named_entities":{"people":[{"name":"Richard Ridinger","role":"Chairman of the Board (newly elected); board member since 2023"},{"name":"Thomas Leysen","role":"outgoing Chairman, retired from the Board"},{"name":"Robin Roothans","role":"Media relations contact"},{"name":"Dave Huizing","role":"Investor relations contact"}],"products":[],"companies":[{"name":"dsm-firmenich","ticker":"DSFIR","relationship":"filer"}],"dollarAmounts":[{"amount":"€9 billion","context":"revenues for Continuing Operations following divestment of Animal Nutrition & Health"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-19T12:49:50.440Z","global_importance":25,"audience_relevance":20,"importance_components":{"tickerTier":"large-cap foreign issuer","eventGravity":"routine governance confirmation","preAnnounced":true,"householdBrandBoost":"moderate European household name but limited US retail audience"}},"durationMs":4227,"modelName":"glm-5.3-flashx"}}